These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8040940)

  • 21. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
    Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW
    J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of pressure-activated channel in intact vascular endothelium of stroke-prone spontaneously hypertensive rats.
    Köhler R; Grundig A; Brakemeier S; Rothermund L; Distler A; Kreutz R; Hoyer J
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):716-21. PubMed ID: 11465659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraplegia differentially increases arterial blood pressure related cardiovascular disease risk factors in normotensive and hypertensive rats.
    Rodenbaugh DW; Collins HL; DiCarlo SE
    Brain Res; 2003 Aug; 980(2):242-8. PubMed ID: 12867264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats.
    Chillon JM; Baumbach GL
    Hypertension; 2001 Jun; 37(6):1388-93. PubMed ID: 11408382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamics and monoamine oxidase activity in spontaneously hypertensive rats (SHR).
    Yasuhara H; Tonooka M; Wada I; Oguchi K; Sakamoto K; Kamijo K
    Jpn J Pharmacol; 1983 Oct; 33(5):1057-64. PubMed ID: 6645113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.
    Petrinec D; Liao S; Holmes DR; Reilly JM; Parks WC; Thompson RW
    J Vasc Surg; 1996 Feb; 23(2):336-46. PubMed ID: 8637112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin suppresses experimental aortic aneurysm expansion.
    Kalyanasundaram A; Elmore JR; Manazer JR; Golden A; Franklin DP; Galt SW; Zakhary EM; Carey DJ
    J Vasc Surg; 2006 Jan; 43(1):117-24. PubMed ID: 16414398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperinsulinaemia increases blood pressure in genetically predisposed spontaneously hypertensive rats but not in normotensive Wistar-Kyoto rats.
    Zimlichman R; Matas Z; Gass S; Shahar C; Barg J; Nakash I; Zeidel L; Eliahou H
    J Hypertens; 1995 Sep; 13(9):1009-13. PubMed ID: 8586818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.
    Owens GK
    Hypertension; 1987 Feb; 9(2):178-87. PubMed ID: 3546119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial smooth muscle contractions in spontaneously hypertensive rats on a high-calcium diet.
    Pörsti I
    J Hypertens; 1992 Mar; 10(3):255-63. PubMed ID: 1315823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental study of determinants of aneurysmal expansion of the abdominal aorta.
    Anidjar S; Dobrin PB; Chejfec G; Michel JB
    Ann Vasc Surg; 1994 Mar; 8(2):127-36. PubMed ID: 8198945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant erythropoietin increases blood pressure in experimental hypertension and uraemia without change in vascular cytosolic calcium.
    Roger SD; Fluck RJ; McMahon AC; Raine AE
    Nephron; 1996; 73(2):212-8. PubMed ID: 8773347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of AAA in a rat model by treatment with ACEI perindopril.
    Xiong F; Zhao J; Zeng G; Huang B; Yuan D; Yang Y
    J Surg Res; 2014 Jun; 189(1):166-73. PubMed ID: 24602481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic arterial compliance in normotensive and hypertensive rats.
    Levy BI; Benessiano J; Poitevin P; Lukin L; Safar ME
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S28-32. PubMed ID: 2409365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness, affinity constants and beta-adrenoceptor reserves for isoprenaline on aortae from normo-, pre- and hypertensive rats.
    Chen YY; Doggrell SA
    J Pharm Pharmacol; 2002 Apr; 54(4):515-22. PubMed ID: 11999129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats.
    Hendley ED; Ohlsson WG
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H583-9. PubMed ID: 1877683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats.
    Perusquía M; Herrera N; Ferrer M; Stallone JN
    J Steroid Biochem Mol Biol; 2017 Mar; 167():106-114. PubMed ID: 27888135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.